NO810962L - Fremgangsmaate for fremstilling av nye derivater av tioformamid - Google Patents

Fremgangsmaate for fremstilling av nye derivater av tioformamid

Info

Publication number
NO810962L
NO810962L NO810962A NO810962A NO810962L NO 810962 L NO810962 L NO 810962L NO 810962 A NO810962 A NO 810962A NO 810962 A NO810962 A NO 810962A NO 810962 L NO810962 L NO 810962L
Authority
NO
Norway
Prior art keywords
mixture
solution
minutes
pyridyl
kpa
Prior art date
Application number
NO810962A
Other languages
English (en)
Norwegian (no)
Inventor
Jean-Claude Aloup
Jean Bouchaudon
Daniel Farge
Claude James
Original Assignee
Rhone Poulenc Ind
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Ind filed Critical Rhone Poulenc Ind
Publication of NO810962L publication Critical patent/NO810962L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/12Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/32Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/08Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D411/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms
    • C07D411/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D411/04Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Quinoline Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Cephalosporin Compounds (AREA)
  • Instructional Devices (AREA)
  • Toys (AREA)
  • Lasers (AREA)
NO810962A 1980-08-18 1981-03-20 Fremgangsmaate for fremstilling av nye derivater av tioformamid NO810962L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8018035A FR2488609A1 (fr) 1980-08-18 1980-08-18 Nouveaux derives de la thioformamide, leur preparation et les medicaments qui les contiennent

Publications (1)

Publication Number Publication Date
NO810962L true NO810962L (no) 1982-02-19

Family

ID=9245232

Family Applications (1)

Application Number Title Priority Date Filing Date
NO810962A NO810962L (no) 1980-08-18 1981-03-20 Fremgangsmaate for fremstilling av nye derivater av tioformamid

Country Status (24)

Country Link
US (1) US4379154A (el)
EP (2) EP0046417B1 (el)
JP (1) JPS5742687A (el)
KR (1) KR850001043B1 (el)
AT (1) ATE14730T1 (el)
CA (1) CA1161039A (el)
DE (1) DE3161861D1 (el)
DK (1) DK158735C (el)
ES (2) ES8202819A1 (el)
FI (1) FI810835L (el)
FR (1) FR2488609A1 (el)
GR (1) GR72767B (el)
HU (1) HU187325B (el)
IE (1) IE51263B1 (el)
IL (1) IL62380A (el)
MA (1) MA19106A1 (el)
NO (1) NO810962L (el)
NZ (1) NZ197071A (el)
OA (1) OA06767A (el)
PH (1) PH16520A (el)
PL (2) PL130679B1 (el)
PT (1) PT72718B (el)
SU (2) SU1093248A3 (el)
ZA (1) ZA813159B (el)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2511371A1 (fr) * 1981-08-11 1983-02-18 Rhone Poulenc Sante Nouveaux nitriles heterocycliques, leur preparation et leur utilisation pour la preparation de medicaments
FR2528849B1 (fr) * 1982-06-17 1985-06-21 Rhone Poulenc Sante Nouveaux derives de la thioformamide, leur preparation et les medicaments qui les contiennent
FR2573428B1 (fr) * 1984-11-20 1987-01-30 Rhone Poulenc Sante Nouveaux derives de la thioformamide, leur preparation et les medicaments qui les contiennent
GB8907306D0 (en) * 1989-03-31 1989-05-17 May & Baker Ltd New compositions of matter
FR2653770B1 (fr) * 1989-10-31 1992-01-03 Rhone Poulenc Sante Procede de preparation de (pyridyl-3)-2 tetrahydrothiopyrannecarbothioamide-2-oxydes-1-(1r,2r), les (pyridyl-3)-2 tetrhydrothiopyrannecarbothioamide-2-oxydes-1-(1r,2r) ainsi obtenus et les compositions pharmaceutiques qui les contiennent.
JPH04211048A (ja) * 1990-03-05 1992-08-03 Mitsubishi Kasei Corp チオカルバモイルアセトニトリル誘導体
WO1993008168A1 (en) * 1991-10-14 1993-04-29 Eisai Co., Ltd. Thioformamide derivative
US5625068A (en) * 1995-06-05 1997-04-29 American Cyanamid Company Substituted quinoline herbicide intermediates and process

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1056205B (it) * 1970-07-30 1982-01-30 Fujisawa Pharmaceutical Co Composto a paste di derivati tioa cetammidici e loro sali procedimento per il suo ottenimento e composizioni che lo contengono
DK627174A (el) * 1974-01-17 1975-09-08 Ciba Geigy Ag
IE49570B1 (en) * 1979-03-30 1985-10-30 Rhone Poulenc Ind 2-(pyrid-2-yl)tetrahydrothiophene derivatives
FR2452488A1 (fr) * 1979-03-30 1980-10-24 Rhone Poulenc Ind Nouveaux derives du (pyridyl-2)-2 tetrahydrothiophene, leur preparation et les medicaments qui les contiennent
JPS6134433A (ja) * 1984-08-31 1986-02-18 Nippon Telegr & Teleph Corp <Ntt> xy平面位置決め用アクチユエ−タ装置

Also Published As

Publication number Publication date
ZA813159B (en) 1983-07-27
GR72767B (el) 1983-12-02
ES501060A0 (es) 1982-02-01
KR850001043B1 (ko) 1985-07-19
ES8301475A1 (es) 1982-12-01
DK130781A (da) 1982-02-19
US4379154A (en) 1983-04-05
DE3161861D1 (en) 1984-02-16
IE51263B1 (en) 1986-11-26
PH16520A (en) 1983-11-10
SU1209029A3 (ru) 1986-01-30
DK158735C (da) 1990-12-03
EP0077083A1 (fr) 1983-04-20
MA19106A1 (fr) 1981-10-01
ES8202819A1 (es) 1982-02-01
NZ197071A (en) 1983-07-15
IL62380A0 (en) 1981-05-20
JPH0259150B2 (el) 1990-12-11
PL130530B1 (en) 1984-08-31
EP0077083B1 (fr) 1985-08-07
ES503727A0 (es) 1982-12-01
OA06767A (fr) 1982-12-31
IL62380A (en) 1984-11-30
SU1093248A3 (ru) 1984-05-15
EP0046417B1 (fr) 1984-01-11
PL230552A1 (el) 1982-03-01
FR2488609A1 (fr) 1982-02-19
HU187325B (en) 1985-12-28
FR2488609B1 (el) 1984-05-04
PT72718A (fr) 1981-04-01
JPS5742687A (en) 1982-03-10
ATE14730T1 (de) 1985-08-15
DK158735B (da) 1990-07-09
KR830006277A (ko) 1983-09-20
IE811036L (en) 1982-02-18
PL130679B1 (en) 1984-08-31
EP0046417A1 (fr) 1982-02-24
FI810835L (fi) 1982-02-19
PT72718B (fr) 1982-03-24
CA1161039A (fr) 1984-01-24

Similar Documents

Publication Publication Date Title
JP4533466B2 (ja) 蛋白質イソプレニルトランスフェラーゼの阻害剤
CA2223062C (en) 3-pyridyloxyalkyl heterocyclic ether compounds useful in controlling chemical synaptic transmission
DE69434041T2 (de) Trisubstituierte phenyl-derivate, verfahren zu deren herstellung und deren verwendung als phosphodiesterase (typ iv) hemmstoffe
CN102482234B (zh) 含氮化合物及其用于治疗心房纤维性颤动的药物组合物
AU758325B2 (en) Imidazole compounds and medicinal use thereof
CA2134865A1 (en) Substituted heterocyclic carboxamide esters, their preparation and their use as pharmaceuticals
EP1858854A1 (en) Pyridine-2-carboxamide derivatives as mglur5 antagonists
EP1740569A1 (de) Imidazol-derivate als tafia-inhibitoren
NO810962L (no) Fremgangsmaate for fremstilling av nye derivater av tioformamid
CS203995B2 (en) Method of producing heterocyclic compounds
SA05260027B1 (ar) مركبات بيريدين
Mountford et al. Synthesis of N-heterocyclic ligands for use in affinity and mixed mode chromatography
NO863228L (no) Fremgangsmaate for fremstilling av farmakodynamisk aktive benzimidazol-derivater.
CN109715614A (zh) 用脲和苯基取代的6元环胺或内酰胺
NO832184L (no) Fremgangsmaate for fremstilling av nye derivater av tioformamid
FI66862C (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 2-(pyridyl-2)-tetrahydrotiofenderivat
EP0095104B1 (en) Process for the preparation of pyridyl and quinolyl imidazolinones
NZ206808A (en) Pyrrole derivatives
AU2003267000B2 (en) 2-thio-substituted imidazole derivatives and their use in pharmaceutics
SU1037840A3 (ru) Способ получени производных 2-/2-пиридил/-тетрагидротиофена
KR840000075B1 (ko) 2-(피리드-2-일)테트라하이드로티오펜 유도체의 제조방법
JPS6134433B2 (el)
JPH01211584A (ja) 新規化合物、その製法及びそれを含む医薬組成物
CS228505B2 (en) Method for the production of new 2-/2-pyridyl/tetrahydrothiophene derivates
McKinnon et al. Conversion of some azaheterocyclic-acetic esters and-acetonitriles into fused heterocycles